Apnimed Reports Positive Topline Results from Second Phase 3 Trial of AD109, Reinforcing Potential of First Oral Pill for Obstructive Sleep Apnea PressReach · Jul 23, 2025
AIRS Medical Accelerates SwiftMR™ Adoption in Latin America With Key Partnerships PressReach · Jul 23, 2025
Trailhead Biosystems® Expands Human Cell-Based Product Line with iPSC-Derived A9 Dopaminergic Neurons PressReach · Jul 23, 2025
IDEAYA Biosciences Announces 10-Year Anniversary R&D Day on September 8, 2025 to Present Multiple Clinical Data Updates and Outline Future Growth Strategy PressReach · Jul 23, 2025
LUNGevity Foundation Awarded Funding to Launch Groundbreaking Citizen Scientist Program for Lung Cancer Community PressReach · Jul 22, 2025
The Quell Foundation Appoints Mike Wynn as Director of the First Responder Resilience Project PressReach · Jul 22, 2025
METiS Technologies Showcases AI-Powered Nanodelivery Platform at the 2025 Controlled Release Society Annual Meeting PressReach · Jul 22, 2025
Shoulder Innovations Announces Closing of a $40 Million Convertible Notes Financing PressReach · Jul 21, 2025
CorestemChemon Expands Global CRO Reach with ATG Lifetech, Targeting Next-Gen Preclinical Services PressReach · Jul 21, 2025
IDEAYA Biosciences to Participate in Upcoming July 2025 Investor Relations Event PressReach · Jul 21, 2025
